STAAR SURGICAL COMPANY
10-Q, EX-27, 2000-11-13
OPHTHALMIC GOODS
Previous: STAAR SURGICAL COMPANY, 10-Q, 2000-11-13
Next: HECLA MINING CO/DE/, 10-Q, 2000-11-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-29-2000
<PERIOD-END>                               SEP-29-2000
<CASH>                                      21,760,268
<SECURITIES>                                         0
<RECEIVABLES>                               10,044,316
<ALLOWANCES>                                   743,273
<INVENTORY>                                 19,570,066
<CURRENT-ASSETS>                            59,930,046
<PP&E>                                      28,757,941
<DEPRECIATION>                              16,369,203
<TOTAL-ASSETS>                              96,648,616
<CURRENT-LIABILITIES>                       37,691,470
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       152,537
<OTHER-SE>                                  55,651,403
<TOTAL-LIABILITY-AND-EQUITY>                96,648,616
<SALES>                                     40,475,964
<TOTAL-REVENUES>                            40,650,071
<CGS>                                       20,964,217
<TOTAL-COSTS>                               39,061,195
<OTHER-EXPENSES>                                96,803
<LOSS-PROVISION>                               126,353
<INTEREST-EXPENSE>                           1,223,729
<INCOME-PRETAX>                           (23,723,973)
<INCOME-TAX>                               (6,077,355)
<INCOME-CONTINUING>                       (17,708,979)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (17,708,979)
<EPS-BASIC>                                     (1.21)
<EPS-DILUTED>                                   (1.21)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission